BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 33815402)

  • 1. The Protective Effects of IL-31RA Deficiency During Bleomycin-Induced Pulmonary Fibrosis.
    Yombo DJK; Odayar V; Gupta N; Jegga AG; Madala SK
    Front Immunol; 2021; 12():645717. PubMed ID: 33815402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifibrotic effect of Gancao Ganjiang decoction is mediated by PD-1 / TGF-β1 / IL-17A pathway in bleomycin-induced idiopathic pulmonary fibrosis.
    Wang D; Gong L; Li Z; Chen H; Xu M; Rong R; Zhang Y; Zhu Q
    J Ethnopharmacol; 2021 Dec; 281():114522. PubMed ID: 34391863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type V collagen induced tolerance suppresses collagen deposition, TGF-β and associated transcripts in pulmonary fibrosis.
    Vittal R; Mickler EA; Fisher AJ; Zhang C; Rothhaar K; Gu H; Brown KM; Emtiazjoo A; Lott JM; Frye SB; Smith GN; Sandusky GE; Cummings OW; Wilkes DS
    PLoS One; 2013; 8(10):e76451. PubMed ID: 24204629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AAV6-Mediated IL-10 Expression in the Lung Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice.
    Kurosaki F; Uchibori R; Sehara Y; Saga Y; Urabe M; Mizukami H; Hagiwara K; Kume A
    Hum Gene Ther; 2018 Nov; 29(11):1242-1251. PubMed ID: 29598007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine-like factor 1 gene expression is enriched in idiopathic pulmonary fibrosis and drives the accumulation of CD4+ T cells in murine lungs: evidence for an antifibrotic role in bleomycin injury.
    Kass DJ; Yu G; Loh KS; Savir A; Borczuk A; Kahloon R; Juan-Guardela B; Deiuliis G; Tedrow J; Choi J; Richards T; Kaminski N; Greenberg SM
    Am J Pathol; 2012 May; 180(5):1963-78. PubMed ID: 22429962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The IL-33:ST2 axis is unlikely to play a central fibrogenic role in idiopathic pulmonary fibrosis.
    Stephenson KE; Porte J; Kelly A; Wallace WA; Huntington CE; Overed-Sayer CL; Cohen ES; Jenkins RG; John AE
    Respir Res; 2023 Mar; 24(1):89. PubMed ID: 36949463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repetitive intradermal bleomycin injections evoke T-helper cell 2 cytokine-driven pulmonary fibrosis.
    Singh B; Kasam RK; Sontake V; Wynn TA; Madala SK
    Am J Physiol Lung Cell Mol Physiol; 2017 Nov; 313(5):L796-L806. PubMed ID: 28775096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th2 Cytokines Augment IL-31/IL-31RA Interactions via STAT6-dependent IL-31RA Expression.
    Edukulla R; Singh B; Jegga AG; Sontake V; Dillon SR; Madala SK
    J Biol Chem; 2015 May; 290(21):13510-20. PubMed ID: 25847241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-fibrotic effect of inhibition of TGFβ-ALK5 signalling in experimental pulmonary fibrosis in mice is attenuated in the presence of concurrent γ-herpesvirus infection.
    Smoktunowicz N; Alexander RE; Franklin L; Williams AE; Holman B; Mercer PF; Jarai G; Scotton CJ; Chambers RC
    Dis Model Mech; 2015 Sep; 8(9):1129-39. PubMed ID: 26138704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of bleomycin-induced lung fibrosis is independent of IL-16.
    Glass WG; Argentieri RL; Bracht M; Farrell FX; Das AM; Del Vecchio AM; Hogaboam CM; Murray LA
    Cytokine; 2009 Apr; 46(1):17-23. PubMed ID: 19232499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of glutamine transporter ASCT2 mitigates bleomycin-induced pulmonary fibrosis in mice.
    Lian N; Jin H; Zhu W; Zhang C; Qi Y; Jiang M; Mao J; Lu X; Zhao F; Xi B; Qi X; Li Y
    Acta Histochem; 2022 Dec; 124(8):151961. PubMed ID: 36265204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis.
    Comeglio P; Filippi S; Sarchielli E; Morelli A; Cellai I; Corcetto F; Corno C; Maneschi E; Pini A; Adorini L; Vannelli GB; Maggi M; Vignozzi L
    J Steroid Biochem Mol Biol; 2017 Apr; 168():26-37. PubMed ID: 28115235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A protective role for IL-13 receptor α 1 in bleomycin-induced pulmonary injury and repair.
    Karo-Atar D; Bordowitz A; Wand O; Pasmanik-Chor M; Fernandez IE; Itan M; Frenkel R; Herbert DR; Finkelman FD; Eickelberg O; Munitz A
    Mucosal Immunol; 2016 Jan; 9(1):240-53. PubMed ID: 26153764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FLUOROFENIDONE ATTENUATES PULMONARY INFLAMMATION AND FIBROSIS BY INHIBITING THE IL-11/MEK/ERK SIGNALING PATHWAY.
    Song C; Liu X; Tan W; Guo X; Mao Y; Zhou Q; Geng S; Hu Y
    Shock; 2022 Aug; 58(2):137-146. PubMed ID: 36166195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IRAK-M promotes alternative macrophage activation and fibroproliferation in bleomycin-induced lung injury.
    Ballinger MN; Newstead MW; Zeng X; Bhan U; Mo XM; Kunkel SL; Moore BB; Flavell R; Christman JW; Standiford TJ
    J Immunol; 2015 Feb; 194(4):1894-904. PubMed ID: 25595781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injury.
    Smith MR; Gangireddy SR; Narala VR; Hogaboam CM; Standiford TJ; Christensen PJ; Kondapi AK; Reddy RC
    Am J Physiol Lung Cell Mol Physiol; 2010 May; 298(5):L616-25. PubMed ID: 20061443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surfactant protein-D regulates effector cell function and fibrotic lung remodeling in response to bleomycin injury.
    Aono Y; Ledford JG; Mukherjee S; Ogawa H; Nishioka Y; Sone S; Beers MF; Noble PW; Wright JR
    Am J Respir Crit Care Med; 2012 Mar; 185(5):525-36. PubMed ID: 22198976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IRAK-M Regulates Monocyte Trafficking to the Lungs in Response to Bleomycin Challenge.
    Reader BF; Sethuraman S; Hay BR; Thomas Becket RV; Karpurapu M; Chung S; Lee YG; Christman JW; Ballinger MN
    J Immunol; 2020 May; 204(10):2661-2670. PubMed ID: 32253243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CoQ10 enhances the efficacy of airway basal stem cell transplantation on bleomycin-induced idiopathic pulmonary fibrosis in mice.
    Liu H; Liu S; Jiang J; Zhang Y; Luo Y; Zhao J; Xu J; Xie Y; Liao W; Wang W; Nie Y; Li S; Deng W
    Respir Res; 2022 Feb; 23(1):39. PubMed ID: 35219329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysophosphatidic acid receptor-2 deficiency confers protection against bleomycin-induced lung injury and fibrosis in mice.
    Huang LS; Fu P; Patel P; Harijith A; Sun T; Zhao Y; Garcia JG; Chun J; Natarajan V
    Am J Respir Cell Mol Biol; 2013 Dec; 49(6):912-22. PubMed ID: 23808384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.